about us about us home about us as a biopharmaceutical company our team of dedicated individuals is focused on discovering and developing innovative antibodybased therapeutics for the treatment of cancer as well as various autoimmune disorders and infectious diseases our core scientific expertise is in the field of protein engineering and our product candidates have been created primarily through our proprietary protein engineering platforms including our dualaffinity retargeting or dart® and fc optimization platforms these platforms are generally focused on the creation of antibodies antibody derivatives and antibodylike molecules for use as therapeutic agents our product candidates and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe our two lead product candidates were developed using our proprietary fc optimization platform and include margetuximab an antiher antibody that we are evaluating in a phase  clinical trial in patients with metastatic breast cancer and enoblituzumab an antibh antibody that we believe has the potential for broad impact across a variety of different tumor types through multiple potential mechanisms of action in addition we have created a number of product candidates based on our proprietary dart platform and now have five of these in human clinical development please note – you will leave a website owned by macrogenics inc macrogenics is not responsible for any content on the third party website ok close homepage broad pipeline of differentiated product candidates to fight cancer  autoimmune disorders learn more enrolling her patients with metastatic breast cancer in phase  sophia study learn more leading multispecific antibody technology platforms and protein engineering expertise learn more breakthrough biologics lifechanging medicines learn more fullyintegrated antibodybased development capabilities including gmp manufacturing learn more focused on developing innovative medicines for patients with unmet needs learn more breakthrough biologics lifechanging medicines learn more nextgeneration antibody basedtechnology platforms created through ourprotein engineering expertise learn more overview we are a clinicalstage biopharmaceutical company focused on discovering and developing innovative monoclonal antibodybased therapeutics for the treatment of cancer autoimmune disorders and infectious diseases corporate fact sheet learn more we’re hiring our success depends on the talent and dedication of the staff we hire we are continually expanding our network of individuals who are excited about making a difference in the lives of patients learn more latest news phase  data for flotetuzumab macrogenics cd x cd dart® molecule accepted for oral presentation at esmo congress read more phase  data for flotetuzumab macrogenics cd x cd dart® molecule accepted for oral presentation at esmo congress read more learn more please note – you will leave a website owned by macrogenics inc macrogenics is not responsible for any content on the third party website ok close careers careers at macrogenics home careers at macrogenics open positions macrogenics is focused on developing novel medicines to treat lifethreatening diseases we consider our employees to be our most valuable asset in the success of our business our culture provides an atmosphere of innovation open communication and collaboration employees in every department can see firsthand how they contribute to the success of the organization in our pursuit of excellence we are searching for talented individuals of the highest caliber we seek employees who share our core values of teamwork innovation corporate responsibility initiative and integrity as we advance in science we believe in continuing to foster a personally and professionally fulfilling environment based on mutual respect and the drive to accomplish our mission these are exciting times at macrogenics as we continue to work together to build our team view current openings resumes will be reviewed by the hiring manager and applicants will be contacted directly if additional information is required macrogenics is proud to be an equal opportunityaffirmative action employer employment selection and related decisions are made without regard to sex gender identity race age disability religion national origin color veteran status or any other protected class we are committed to working with and providing reasonable accommodation to individuals with disabilities if because of a medical condition or disability you need a reasonable accommodation for any part of the employment process please email infomacrogenicscom or call   andor  for ttdtty service macrogenics’ equal employment opportunityaffirmation action program statement of policy equal employment opportunity is the law english equal employment opportunity is the law spanish eeo is the law supplemental poster pay transparency nondiscrimination provision please note – you will leave a website owned by macrogenics inc macrogenics is not responsible for any content on the third party website ok close current openings current openings your browser does not support inline frames or is currently configured not to display inline frames content can be viewed at the actual source page iframesrc please note – you will leave a website owned by macrogenics incmacrogenics is not responsible for any content on the third party website ok close pipeline pipeline home pipeline overview macrogenics has a diverse portfolio of proprietary product candidates with several clinical trials currently underway or planned for the near future set forth below is the company’s development pipeline of product candidates for which we have retained commercialization or copromotion rights in the us or more broadly program target indications preind phase  phase  phase  partner our commercial rights oncology margetuximab her green cross worldwide except korea breast  “sophia” placeholder placeholder placeholder placeholder gastric antipd placeholder placeholder placeholder enoblituzumab b–h worldwide solid tumors mono placeholder placeholder solid tumors antictla placeholder placeholder solid tumors antipd placeholder placeholder flotetuzumab cd x cd servier north america japan korea india amlmds placeholder placeholder mgd gpa x cd servier north america japan korea india colorectal placeholder placeholder mgd cd x cd janssen us copromote bcell malignancies placeholder placeholder mgd bh x cd worldwide solid tumors placeholder placeholder mga pd worldwide solid tumors placeholder placeholder mgd pd x lag worldwide solid tumorsheme placeholder placeholder autoimmune  infectious diseases teplizumab cd niddknih worldwide type  diabetes prev placeholder placeholder placeholder mgd cdb x cdb worldwide autoimmune disorders placeholder placeholder mgd hiv x cd niaidnih worldwide hiv placeholder oncology margetuximab her breast  “sophia” preind phase  phase  phase  placeholder placeholder placeholder placeholder gastric antipd preind phase  phase  phase  placeholder placeholder placeholder partnergreen cross our commercial rightsworldwide except korea enoblituzumab b–h solid tumors mono preind phase  phase  phase  placeholder placeholder solid tumors antictla preind phase  phase  phase  placeholder placeholder solid tumors antipd preind phase  phase  phase  placeholder placeholder our commercial rightsworldwide flotetuzumab cd x cd amlmds preind phase  phase  phase  placeholder placeholder partnerservier our commercial rightsnorth america japan korea india mgd gpa x cd colorectal preind phase  phase  phase  placeholder placeholder partnerservier our commercial rightsnorth america japan korea india mgd cd x cd bcell malignancies preind phase  phase  phase  placeholder placeholder partnerjanssen our commercial rightsus copromote mgd bh x cd solid tumors preind phase  phase  phase  placeholder placeholder our commercial rightsworldwide mga pd solid tumors preind phase  phase  phase  placeholder placeholder our commercial rightsworldwide mgd pd x lag solid tumorsheme preind phase  phase  phase  placeholder placeholder our commercial rightsworldwide autoimmune  infectious diseases teplizumab cd type  diabetes prev preind phase  phase  phase  placeholder placeholder placeholder partnerniddknih our commercial rightsworldwide mgd cdb x cdb autoimmune disorders preind phase  phase  phase  placeholder placeholder partner our commercial rightsworldwide mgd hiv x cd hiv preind phase  phase  phase  placeholder partnerniaidnih our commercial rightsworldwide  option for us copromote may elect to fund portion of latestage development in exchange for us and canada profit share placeholdermab placeholderdart please note – you will leave a website owned by macrogenics inc macrogenics is not responsible for any content on the third party website ok close about us about us home about us as a biopharmaceutical company our team of dedicated individuals is focused on discovering and developing innovative antibodybased therapeutics for the treatment of cancer as well as various autoimmune disorders and infectious diseases our core scientific expertise is in the field of protein engineering and our product candidates have been created primarily through our proprietary protein engineering platforms including our dualaffinity retargeting or dart® and fc optimization platforms these platforms are generally focused on the creation of antibodies antibody derivatives and antibodylike molecules for use as therapeutic agents our product candidates and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe our two lead product candidates were developed using our proprietary fc optimization platform and include margetuximab an antiher antibody that we are evaluating in a phase  clinical trial in patients with metastatic breast cancer and enoblituzumab an antibh antibody that we believe has the potential for broad impact across a variety of different tumor types through multiple potential mechanisms of action in addition we have created a number of product candidates based on our proprietary dart platform and now have five of these in human clinical development please note – you will leave a website owned by macrogenics inc macrogenics is not responsible for any content on the third party website ok close investors  macrogenics inc investors home investors facebook google linkedin twitter email rss macrogenics is a clinicalstage biopharmaceutical company focused on discovering and developing innovative monoclonal antibodybased therapeutics for the treatment of cancer as well as autoimmune disorders and infectious diseases the company generates its pipeline of product candidates from its proprietary suite of nextgeneration antibodybased technology platforms the combination of macrogenics technology platforms and protein engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies corporate fact sheet   press releases jul   phase  data for flotetuzumab macrogenics cd x cd dart® molecule accepted for oral presentation at esmo congress  jun   macrogenics presents updated data from phase  study of mgd at annual european congress of rheumatology eular  view all press releases » events  presentations jun   macrogenics presentation at the annual european congress of rheumatology eular  jun   at  am et trialsinprogress poster presentation at asco annual meeting  view all events  presentations »    mo  mo  yr nasdaq mgnx  change   day high  day low  volume   pm et on jul   delayed at least  minutes provided by esignal please note – you will leave a website owned by macrogenics inc macrogenics is not responsible for any content on the third party website ok close macrogenics inc  product pipeline review   trends statistics segment and forecasts market size share analysis  market research store     gmt office hours  uscan toll free  us office no home categories become publisher news about us contact us select category consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media semiconductor chemical and materials metallurgical market research search home  life sciences  pharmaceuticals macrogenics inc  product pipeline review   published jul  format pdf  global markets direct  number of pages   code mrs   report details table of content inquiry for buying request sample macrogenics inc  product pipeline review   summary global markets direct’s ‘macrogenics inc  product pipeline review  ’ provides an overview of the macrogenics inc’s pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by macrogenics inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope  the report provides a snapshot of the pipeline therapeutic landscape of macrogenics inc  the report provides overview of macrogenics inc including its business description key facts and locations and subsidiaries  the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities  the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages  the report assesses macrogenics inc’s pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type  the report features macrogenics inc’s outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy  evaluate macrogenics inc’s strategic position with total access to detailed information on its product pipeline  gain strategically significant competitor information analysis and insights to formulate effective rd strategies  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  identify and understand important and diverse types of therapeutics under development for macrogenics inc  identify potential new clients or partners in the target demographic  plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics  devise corrective measures for pipeline projects by understanding macrogenics inc’s pipeline depth and focus of pipeline therapeutics  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents table of contents  list of tables  list of figures  macrogenics inc snapshot  macrogenics inc overview  key information  key facts  macrogenics inc  research and development overview  key therapeutic areas  macrogenics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  partnered products  partnered productscombination treatment modalities  pipeline products  outlicensed products  outlicensed productscombination treatment modalities  macrogenics inc  pipeline products glance  macrogenics inc  late stage pipeline products  phase iii productscombination treatment modalities  macrogenics inc  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  macrogenics inc  early stage pipeline products  preclinical productscombination treatment modalities  macrogenics inc  drug profiles  margetuximab  product description  mechanism of action  rd progress  teplizumab  product description  mechanism of action  rd progress  enoblituzumab  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  mga  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  monoclonal antibodies to target dr for oncology  product description  mechanism of action  rd progress  monoclonal antibodies to target epha and cd for breast cancer  product description  mechanism of action  rd progress  monoclonal antibodies to target ilralpha and cd for melanoma glioblastoma multiforme and medulloblastoma  product description  mechanism of action  rd progress  monoclonal antibodies to target ror and cd for oncology  product description  mechanism of action  rd progress  monoclonal antibody conjugate to target bh for oncology  product description  mechanism of action  rd progress  macrogenics inc  pipeline analysis  macrogenics inc  pipeline products by target  macrogenics inc  pipeline products by route of administration  macrogenics inc  pipeline products by molecule type  macrogenics inc  pipeline products by mechanism of action  macrogenics inc  recent pipeline updates  macrogenics inc  dormant projects  macrogenics inc  company statement  macrogenics inc  locations and subsidiaries  head office  other locations  subsidiaries  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables macrogenics inc key information  macrogenics inc key facts  macrogenics inc  pipeline by indication   macrogenics inc  pipeline by stage of development   macrogenics inc  monotherapy products in pipeline   macrogenics inc  partnered products in pipeline   macrogenics inc  partnered products combination treatment modalities   macrogenics inc  outlicensed products in pipeline   macrogenics inc  outlicensed products combination treatment modalities   macrogenics inc  phase iii   macrogenics inc  phase ii   macrogenics inc  phase i   macrogenics inc  preclinical   macrogenics inc  pipeline by target   macrogenics inc  pipeline by route of administration   macrogenics inc  pipeline by molecule type   macrogenics inc  pipeline products by mechanism of action   macrogenics inc  recent pipeline updates   macrogenics inc  dormant developmental projects  macrogenics inc other locations  macrogenics inc subsidiaries  list of figures macrogenics inc  pipeline by top  indication   macrogenics inc  pipeline by stage of development   macrogenics inc  monotherapy products in pipeline   macrogenics inc  partnered products in pipeline   macrogenics inc  outlicensed products in pipeline   macrogenics inc  pipeline by top  target   macrogenics inc  pipeline by route of administration   macrogenics inc  pipeline by molecule type   macrogenics inc  pipeline products by top  mechanism of action   inquiry for buying please fill your details below to inquire about this report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit request sample please fill your details below to receive sample report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit related reports global and china laboratory ventilators market research report forecast  mar  sp consulting  pages    code  mrs   the global and china laboratory ventilators market research report forecast  is a valuable source of insightful data for business strategists it provides the laboratory ventilators industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this laboratory ventilators market study provides comprehensive data which enh read more united states laboratory ventilators market research report forecast  mar  sp consulting  pages    code  mrs   the united states laboratory ventilators market research report forecast  is a valuable source of insightful data for business strategists it provides the laboratory ventilators industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this laboratory ventilators market study provides comprehensive data which enhanc read more europe laboratory ventilators market research report forecast  mar  sp consulting  pages    code  mrs   the europe laboratory ventilators market research report forecast  is a valuable source of insightful data for business strategists it provides the laboratory ventilators industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this laboratory ventilators market study provides comprehensive data which enhances the read more china laboratory ventilators market research report forecast  mar  sp consulting  pages    code  mrs   the china laboratory ventilators market research report forecast  is a valuable source of insightful data for business strategists it provides the laboratory ventilators industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this laboratory ventilators market study provides comprehensive data which enhances the u read more global laboratory ventilators market professional survey report forecast  mar  sp consulting  pages    code  mrs   this report studies laboratory ventilators in global market especially in north america china europe southeast asia japan and india with production revenue consumption import and export in these regions from  to  and forecast to  this report focuses on top manufacturers in global market with production price revenue and market share for each manufacturer covering harvard apparatus parr instrument harvard bioscience columbus instruments company  company   b read more global laboratory ventilators sales market report forecast  mar  sp consulting  pages    code  mrs   the report offers a comprehensive evaluation of the market it does so via indepth insights understanding market evolution by tracking historical developments and analyzing the present scenario and future projections based on optimistic and likely scenarios each research report serves as a repository of analysis and information for every facet of the market including but not limited to regional markets technology developments types applications and the competitive landscape the read more global laboratory ventilators market research report forecast  mar  sp consulting  pages    code  mrs   the global laboratory ventilators market research report forecast  is a valuable source of insightful data for business strategists it provides the laboratory ventilators industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this laboratory ventilators market study provides comprehensive data which enhances the read more global and china medical bone densitometers market research report forecast  mar  sp consulting  pages    code  mrs   the global and china medical bone densitometers market research report forecast  is a valuable source of insightful data for business strategists it provides the medical bone densitometers industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this medical bone densitometers market study provides comprehensive da read more united states medical bone densitometers market research report forecast  mar  sp consulting  pages    code  mrs   the united states medical bone densitometers market research report forecast  is a valuable source of insightful data for business strategists it provides the medical bone densitometers industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this medical bone densitometers market study provides comprehensive data read more europe medical bone densitometers market research report forecast  mar  sp consulting  pages    code  mrs   the europe medical bone densitometers market research report forecast  is a valuable source of insightful data for business strategists it provides the medical bone densitometers industry overview with growth analysis and historical  futuristic cost revenue demand and supply data as applicable the research analysts provide an elaborate description of the value chain and its distributor analysis this medical bone densitometers market study provides comprehensive data which e read more payment mode single user  usd multi user  usd corporate user  usd latest report  global nonslip epoxy glass flake paint market research report  global parking sensors market research report  global nitrogen oxide sensor market research report  global nuclear density gauge market research report  global automotive interior materials market research report view more latest news global chitosan market set for rapid growth to reach usd  billion by  zion market research has published a new report titled chitosan market for water treatment biomed development of ecommerce to reshape global mobile hotspot router market mobile hotspot is a popular feature on smart phones that provide wireless internet access on many global carotenoids market is expected to reach around usd  billion in  zion market research has published a new report titled carotenoids market by type astaxanthin be soaring demand from food  beverages industry to act as prime driving for ascorbic acid market reports zion market research ascorbic acid is extensively available in nature mostly rich in leafy vegetables and fresh fruits global energy management system ems market is set for a rapid growth and is expected to reach usd  million by  zion market research has published a new report titled energy management system market ems by so view more single user  usd view pricing find help how to order disclaimer faqs return policy sitemap our company about us terms and conditions privacy policy we accept the following payment methods     market research store  market research reports senior management  macrogenics inc senior management home investors corporate governance senior management facebook google linkedin twitter email rss show all scott koenig md phd president and ceo and director dr koenig has been our president and chief executive officer and a director since september  and was one of our cofounders prior to joining us dr koenig served as senior vice president of research at medimmune inc where he participated in the selection and maturation of their product pipeline from  to  he worked in the laboratory of immunoregulation at the national institute of allergy and infectious diseases at the national institutes of health where he investigated the immune response to retroviruses and studied the pathogenesis of aids dr koenig currently serves as chairman of the board of directors of applied genetic technologies corporation and the childrens research institute additionally dr koenig serves on the board of directors of childrens national medical center the international biomedical research alliance and the biotechnology industry organization bio dr koenig received his ab and phd from cornell university and his md from the university of texas health science center in houston we believe that dr koenigs detailed knowledge of our company and his over  years in research and the biotechnology industry provide a valuable contribution to our board of directors james karrels senior vice president chief financial officer and secretary mr karrels senior vice president and chief financial officer joined us in may  and has over  years of experience in finance including approximately  years working for or on behalf of life sciences companies prior to joining us he was at jazz pharmaceuticals inc most recently serving as executive director of finance where he was responsible for the companys financial planning and analysis and investor relations activities prior to joining jazz pharmaceuticals mr karrels spent  years in the investment banking group at merrill lynch most recently serving as a director in the global healthcare group mr karrels holds an mba from stanford university and a bba from the university of notre dame jon wigginton md senior vice president clinical development  chief medical officer dr wigginton joined us as senior vice president clinical research in august  and was promoted to chief medical officer in march  dr wigginton was previously the therapeutic area head immunooncology early clinical research and executive director discovery medicineclinical oncology at bristolmyers from october  to august  while there he led the early clinical development of the bristolmyers’ immunooncology portfolio including antipd and antipdl prior to joining bristolmyers dr wigginton was the director of clinical oncology at merck research laboratories from may  to october  where he led early and latestage clinical development teams for small molecules and biologics during his academic career dr wigginton held several positions at the national cancer institute center for cancer research nciccr including head of investigational biologics section pediatric oncology branch dr wigginton received his md and bs in biology from the university of michigan ezio bonvini md senior vice president research and chief scientific officer dr bonvini senior vice president research and chief scientific officer joined us in june  from  to  dr bonvini was with the fda in the center for biologics evaluation and research or cber which is responsible for regulating therapeutic monoclonal antibodies and other proteins ultimately serving as acting deputy director division of monoclonal antibodies and chief laboratory of immunobiology from  to  dr bonvini was a visiting fellow at the national cancer institute at the national institutes of health dr bonvini received a diploma in science from the scientific lyceum in genoa italy and his md and specialty certification in clinical hematology from the university of genoa school of medicine eric risser senior vice president business development  portfolio management and chief business officer mr risser senior vice president business development  portfolio management and chief business officer joined us in march  prior to joining us mr risser held the position of senior director business development in the pharmaceutical group at johnson  johnson where he worked from  to  before johnson  johnson mr risser started and built a consulting practice that provided counsel to emerging life science companies in the united states and europe earlier in his career mr risser held venture capital and investment banking positions with ba venture partners and lehman brothers holdings inc respectively mr risser holds an mba from stanford university and a ba from yale university tom spitznagel phd senior vice president biopharmaceutical development and manufacturing dr spitznagel senior vice president biopharmaceutical development and manufacturing joined us in   he has overall responsibility for both biopharmaceutical development and manufacturing of macrogenics’ fcoptimized monoclonal antibodies and dualaffinity retargeting dart® antibodylike molecules as well as facilities  prior to joining us he was at human genome sciences most recently serving as vice president of biopharmaceutical development where he was responsible for oversight of analytical development formulation and drug delivery purification sciences and fermentation and cell culture sciences  prior to joining hgs dr spitznagel was a senior scientist at nabi from  and a staff engineer at genetics institute from   dr spitznagel earned his bs in chemical engineering at mit and his phd in chemical engineering at the university of california berkeley lynn cilinski vice president controller and treasurer ms cilinski vice president controller and treasurer joined us in october  prior to joining us ms cilinski spent a year as a consultant to various companies providing services to the government prior to that she spent more than  years with covanta energy inc formerly ogden corporation where she held the position of corporate controller for four subsidiary companies that provided services to the federal government ms cilinski holds a bs from strayer university jeffrey peters acting general counsel and vice president legal affairs jeffrey peters acting general counsel and vice president legal affairs joined us in august  as vice president deputy general counsel before joining macrogenics mr peters most recently served as deputy general counsel health for the biotechnology innovation organization bio the leading national trade association for the biotechnology industry while at bio mr peters served as the primary legal counsel on health regulatory and related matters including legal and policy matters affecting all aspects of biopharmaceutical product discovery development and delivery prior to bio mr peters was with medimmune the global biologics arm of astrazeneca from  through  mr peters had positions of increasing responsibility in the medimmune legal department culminating as vice president and deputy general counsel before joining medimmune mr peters was in private practice for almost a decade joining medimmune from the life sciences practice group at latham  watkins llp in washington dc mr peters holds a jd from the university of pennsylvania law school and a ba in both politics and literature from brandeis university he is a member of the bar in the states of massachusetts and new york and in the district of columbia please note – you will leave a website owned by macrogenics inc macrogenics is not responsible for any content on the third party website ok close macrogenics inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report macrogenics inc  product pipeline review   published by global markets direct product code  published july   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license macrogenics inc  product pipeline review   published july   content info  pages description summary global markets directs macrogenics inc  product pipeline review   provides an overview of the macrogenics incs pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by macrogenics inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope the report provides a snapshot of the pipeline therapeutic landscape of macrogenics inc the report provides overview of macrogenics inc including its business description key facts and locations and subsidiaries the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages the report assesses macrogenics incs pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type the report features macrogenics incs outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy evaluate macrogenics incs strategic position with total access to detailed information on its product pipeline gain strategically significant competitor information analysis and insights to formulate effective rd strategies identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage identify and understand important and diverse types of therapeutics under development for macrogenics inc identify potential new clients or partners in the target demographic plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics devise corrective measures for pipeline projects by understanding macrogenics incs pipeline depth and focus of pipeline therapeutics develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures macrogenics inc snapshot macrogenics inc overview key information key facts macrogenics inc  research and development overview key therapeutic areas macrogenics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  partnered products partnered productscombination treatment modalities pipeline products  outlicensed products outlicensed productscombination treatment modalities macrogenics inc  pipeline products glance macrogenics inc  late stage pipeline products phase iii productscombination treatment modalities macrogenics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities macrogenics inc  early stage pipeline products preclinical productscombination treatment modalities macrogenics inc  drug profiles margetuximab product description mechanism of action rd progress teplizumab product description mechanism of action rd progress enoblituzumab product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress mga product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress monoclonal antibodies to target dr for oncology product description mechanism of action rd progress monoclonal antibodies to target epha and cd for breast cancer product description mechanism of action rd progress monoclonal antibodies to target ilralpha and cd for melanoma glioblastoma multiforme and medulloblastoma product description mechanism of action rd progress monoclonal antibodies to target ror and cd for oncology product description mechanism of action rd progress monoclonal antibody conjugate to target bh for oncology product description mechanism of action rd progress macrogenics inc  pipeline analysis macrogenics inc  pipeline products by target macrogenics inc  pipeline products by route of administration macrogenics inc  pipeline products by molecule type macrogenics inc  pipeline products by mechanism of action macrogenics inc  recent pipeline updates macrogenics inc  dormant projects macrogenics inc  company statement macrogenics inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables macrogenics inc key information macrogenics inc key facts macrogenics inc  pipeline by indication  macrogenics inc  pipeline by stage of development  macrogenics inc  monotherapy products in pipeline  macrogenics inc  partnered products in pipeline  macrogenics inc  partnered products combination treatment modalities  macrogenics inc  outlicensed products in pipeline  macrogenics inc  outlicensed products combination treatment modalities  macrogenics inc  phase iii  macrogenics inc  phase ii  macrogenics inc  phase i  macrogenics inc  preclinical  macrogenics inc  pipeline by target  macrogenics inc  pipeline by route of administration  macrogenics inc  pipeline by molecule type  macrogenics inc  pipeline products by mechanism of action  macrogenics inc  recent pipeline updates  macrogenics inc  dormant developmental projects macrogenics inc other locations macrogenics inc subsidiaries list of figures macrogenics inc  pipeline by top  indication  macrogenics inc  pipeline by stage of development  macrogenics inc  monotherapy products in pipeline  macrogenics inc  partnered products in pipeline  macrogenics inc  outlicensed products in pipeline  macrogenics inc  pipeline by top  target  macrogenics inc  pipeline by route of administration  macrogenics inc  pipeline by molecule type  macrogenics inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved macrogenics inc  product pipeline review    market reports center infomarketreportscentercom  us x login sign up facebook twitter linkedin google  mrc blog youtube macrogenics inc  product pipeline review   home  pharmaceuticals  global markets direct  macrogenics inc  product pipeline review   report details macrogenics inc  product pipeline review   sku gmdsept category pharmaceuticals publisher global markets direct pages  published jul skugmdsept categorypharmaceuticals publisherglobal markets direct pages published onjul request discount pay by wireinvoice description table of content list of figures request sample description macrogenics inc  product pipeline review   summary global markets directs macrogenics inc  product pipeline review   provides an overview of the macrogenics incs pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by macrogenics inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope  the report provides a snapshot of the pipeline therapeutic landscape of macrogenics inc  the report provides overview of macrogenics inc including its business description key facts and locations and subsidiaries  the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities  the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages  the report assesses macrogenics incs pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type  the report features macrogenics incs outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy  evaluate macrogenics incs strategic position with total access to detailed information on its product pipeline  gain strategically significant competitor information analysis and insights to formulate effective rd strategies  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  identify and understand important and diverse types of therapeutics under development for macrogenics inc  identify potential new clients or partners in the target demographic  plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics  devise corrective measures for pipeline projects by understanding macrogenics incs pipeline depth and focus of pipeline therapeutics  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope newspress release precision medicine how the life science industry can improve outcomes through to achieve successful precision medicine at scale and to be able to offer it as an everyday treatment option researchers in drug rd need to better understand and manage the reams of unstructured datread more regenerative medicine market to hit  billion by  the current regenerative medicine market is worth  billion globally and will hit over  billion by  as impact of trump administrationread more  benefits of microneedlingmicroneedling hundreds of tiny pin pricks going into your skin might sound weird but it could just be the best thing that ever happened to your faceread more table of content table of contents table of contents  list of tables  list of figures  macrogenics inc snapshot  macrogenics inc overview  key information  key facts  macrogenics inc  research and development overview  key therapeutic areas  macrogenics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  pipeline products  partnered products  partnered productscombination treatment modalities  pipeline products  outlicensed products  outlicensed productscombination treatment modalities  macrogenics inc  pipeline products glance  macrogenics inc  late stage pipeline products  phase iii productscombination treatment modalities  macrogenics inc  clinical stage pipeline products  phase ii productscombination treatment modalities  phase i productscombination treatment modalities  macrogenics inc  early stage pipeline products  preclinical productscombination treatment modalities  macrogenics inc  drug profiles  margetuximab  product description  mechanism of action  rd progress  teplizumab  product description  mechanism of action  rd progress  enoblituzumab  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  mga  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  mgd  product description  mechanism of action  rd progress  monoclonal antibodies to target dr for oncology  product description  mechanism of action  rd progress  monoclonal antibodies to target epha and cd for breast cancer  product description  mechanism of action  rd progress  monoclonal antibodies to target ilralpha and cd for melanoma glioblastoma multiforme and medulloblastoma  product description  mechanism of action  rd progress  monoclonal antibodies to target ror and cd for oncology  product description  mechanism of action  rd progress  monoclonal antibody conjugate to target bh for oncology  product description  mechanism of action  rd progress  macrogenics inc  pipeline analysis  macrogenics inc  pipeline products by target  macrogenics inc  pipeline products by route of administration  macrogenics inc  pipeline products by molecule type  macrogenics inc  pipeline products by mechanism of action  macrogenics inc  recent pipeline updates  macrogenics inc  dormant projects  macrogenics inc  company statement  macrogenics inc  locations and subsidiaries  head office  other locations  subsidiaries  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of figures list of tables macrogenics inc key information  macrogenics inc key facts  macrogenics inc  pipeline by indication   macrogenics inc  pipeline by stage of development   macrogenics inc  monotherapy products in pipeline   macrogenics inc  partnered products in pipeline   macrogenics inc  partnered products combination treatment modalities   macrogenics inc  outlicensed products in pipeline   macrogenics inc  outlicensed products combination treatment modalities   macrogenics inc  phase iii   macrogenics inc  phase ii   macrogenics inc  phase i   macrogenics inc  preclinical   macrogenics inc  pipeline by target   macrogenics inc  pipeline by route of administration   macrogenics inc  pipeline by molecule type   macrogenics inc  pipeline products by mechanism of action   macrogenics inc  recent pipeline updates   macrogenics inc  dormant developmental projects  macrogenics inc other locations  macrogenics inc subsidiaries  list of figures macrogenics inc  pipeline by top  indication   macrogenics inc  pipeline by stage of development   macrogenics inc  monotherapy products in pipeline   macrogenics inc  partnered products in pipeline   macrogenics inc  outlicensed products in pipeline   macrogenics inc  pipeline by top  target   macrogenics inc  pipeline by route of administration   macrogenics inc  pipeline by molecule type   macrogenics inc  pipeline products by top  mechanism of action   please select license type single user electronic pdf   site user electronic pdf   enterprise wide electronic pdf   add to cart buy now related reports global electrosurgical products market professional survey report  lighting product markets in the top  american countries to  lighting product markets in the top  asian countries to  lighting product markets in the top  european countries to  global lighting product market to  request sample mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send request discount mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send pay by wireinvoice mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  single user electronic pdf site user electronic pdf enterprise wide electronic pdf cd rom hard copy send request quote mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send market reports center  copyright  all rights reserved macrogenics inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports macrogenics inc  product pipeline review   macrogenics inc  product pipeline review   wgr  may  global  pages global markets direct description table of content sample report enquiry before buy related reports macrogenics inc  product pipeline review  summaryglobal markets direct’s ‘macrogenics inc  product pipeline review  ’ provides an overview of the macrogenics inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of macrogenics inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of macrogenics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of macrogenics inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the macrogenics inc’s pipeline productsreasons to buy evaluate macrogenics inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of macrogenics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the macrogenics inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of macrogenics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of macrogenics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of macrogenics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures macrogenics inc snapshot macrogenics inc overview key information key facts macrogenics inc  research and development overview key therapeutic areas macrogenics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  outlicensed products outlicensed productscombination treatment modalities macrogenics inc  pipeline products glance macrogenics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities macrogenics inc  early stage pipeline products preclinical productscombination treatment modalities macrogenics inc  drug profiles margetuximab product description mechanism of action rd progress teplizumab product description mechanism of action rd progress enoblituzumab product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress monoclonal antibodies to inhibit dr for oncology product description mechanism of action rd progress macrogenics inc  pipeline analysis macrogenics inc  pipeline products by target macrogenics inc  pipeline products by route of administration macrogenics inc  pipeline products by molecule type macrogenics inc  pipeline products by mechanism of action macrogenics inc  recent pipeline updates macrogenics inc  dormant projects macrogenics inc  company statement macrogenics inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesmacrogenics inc key information macrogenics inc key facts macrogenics inc  pipeline by indication  macrogenics inc  pipeline by stage of development  macrogenics inc  monotherapy products in pipeline  macrogenics inc  outlicensed products in pipeline  macrogenics inc  outlicensed products combination treatment modalities  macrogenics inc  phase ii  macrogenics inc  phase i  macrogenics inc  preclinical  macrogenics inc  pipeline by target  macrogenics inc  pipeline by route of administration  macrogenics inc  pipeline by molecule type  macrogenics inc  pipeline products by mechanism of action  macrogenics inc  recent pipeline updates  macrogenics inc  dormant developmental projects macrogenics inc other locations macrogenics inc subsidiaries list of figuresmacrogenics inc  pipeline by top  indication  macrogenics inc  pipeline by stage of development  macrogenics inc  monotherapy products in pipeline  macrogenics inc  pipeline by top  target  macrogenics inc  pipeline by top  route of administration  macrogenics inc  pipeline by top  molecule type  macrogenics inc  pipeline products by top  mechanism of action   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send macrogenics inc  product pipeline review   about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in life sciences»pharmaceuticals»pharmaceuticals company reports macrogenics inc  product pipeline review   lowest prices guaranteed length publisher published date sku from   pages global markets direct july  gmd lowest prices guaranteed price from  length  pages publisher global markets direct published date july  sku gmd table of contents close window table of contents macrogenics inc  product pipeline review   printer format global markets direct macrogenics inc snapshot macrogenics inc overview key information key facts macrogenics inc  research and development overview key therapeutic areas macrogenics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  partnered products partnered productscombination treatment modalities pipeline products  outlicensed products outlicensed productscombination treatment modalities macrogenics inc  pipeline products glance macrogenics inc  late stage pipeline products phase iii productscombination treatment modalities macrogenics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities macrogenics inc  early stage pipeline products preclinical productscombination treatment modalities macrogenics inc  drug profiles margetuximab product description mechanism of action rd progress teplizumab product description mechanism of action rd progress enoblituzumab product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress mga product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress monoclonal antibodies to target dr for oncology product description mechanism of action rd progress monoclonal antibodies to target epha and cd for breast cancer product description mechanism of action rd progress monoclonal antibodies to target ilralpha and cd for melanoma glioblastoma multiforme and medulloblastoma product description mechanism of action rd progress monoclonal antibodies to target ror and cd for oncology product description mechanism of action rd progress monoclonal antibody conjugate to target bh for oncology product description mechanism of action rd progress macrogenics inc  pipeline analysis macrogenics inc  pipeline products by target macrogenics inc  pipeline products by route of administration macrogenics inc  pipeline products by molecule type macrogenics inc  pipeline products by mechanism of action macrogenics inc  recent pipeline updates macrogenics inc  dormant projects macrogenics inc  company statement macrogenics inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesmacrogenics inc key information macrogenics inc key facts macrogenics inc  pipeline by indication  macrogenics inc  pipeline by stage of development  macrogenics inc  monotherapy products in pipeline  macrogenics inc  partnered products in pipeline  macrogenics inc  partnered products combination treatment modalities  macrogenics inc  outlicensed products in pipeline  macrogenics inc  outlicensed products combination treatment modalities  macrogenics inc  phase iii  macrogenics inc  phase ii  macrogenics inc  phase i  macrogenics inc  preclinical  macrogenics inc  pipeline by target  macrogenics inc  pipeline by route of administration  macrogenics inc  pipeline by molecule type  macrogenics inc  pipeline products by mechanism of action  macrogenics inc  recent pipeline updates  macrogenics inc  dormant developmental projects macrogenics inc other locations macrogenics inc subsidiaries list of figuresmacrogenics inc  pipeline by top  indication  macrogenics inc  pipeline by stage of development  macrogenics inc  monotherapy products in pipeline  macrogenics inc  partnered products in pipeline  macrogenics inc  outlicensed products in pipeline  macrogenics inc  pipeline by top  target  macrogenics inc  pipeline by route of administration  macrogenics inc  pipeline by molecule type  macrogenics inc  pipeline products by top  mechanism of action  description close window description macrogenics inc  product pipeline review   printer format global markets direct macrogenics inc  product pipeline review  summaryglobal markets direct’s ‘macrogenics inc  product pipeline review  ’ provides an overview of the macrogenics inc’s pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by macrogenics inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basisthe report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantagenote certain sections in the report may be removed or altered based on the availability and relevance of datascopethe report provides a snapshot of the pipeline therapeutic landscape of macrogenics incthe report provides overview of macrogenics inc including its business description key facts and locations and subsidiariesthe report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages the report assesses macrogenics inc’s pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type the report features macrogenics inc’s outlicensed and partnered product portfolio and summarizes its dormant and discontinued projectsreasons to buyevaluate macrogenics inc’s strategic position with total access to detailed information on its product pipelinegain strategically significant competitor information analysis and insights to formulate effective rd strategiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage identify and understand important and diverse types of therapeutics under development for macrogenics incidentify potential new clients or partners in the target demographicplan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeuticsdevise corrective measures for pipeline projects by understanding macrogenics inc’s pipeline depth and focus of pipeline therapeuticsdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope search inside this report close window search inside this report online download  purchase site license  purchase global site license  purchase   research assistance us  intl  download our ebook how to succeed using market research learn how to effectively navigate the market research process to help guide your organization on the journey to success download ebook share this report other tasks printer format order by fax currency converter pharmaceuticals market research reports  pharmaceuticals industry analysis  marketresearchcom about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in market research » life sciences pharmaceuticals market research reports  industry analysis the pharmaceutical industry is directly impacted by the research conducted with prescription drugs vaccines and otc drugs being manufactured based on findings from the study of life sciences clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat the market research available can provide investors and analysts credible information on the direction of pharmaceuticals anesthesia drug delivery pricing regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction show more show less filter your search filter your search anesthesia  antibiotic  biopharmaceuticals  biopharmacology  clinical nutrition  clinical trial  country overviews  dietary supplements  diseases  conditions  drug delivery  drug discovery  general pharmaceuticals  generics drugs  manufacturing packaging  detailing  overthecounter drugs  pharmaceuticals company reports  pharmacy  distribution  prescription drugs  pricing  regulation  policy  research  development  technology  therapeutic area  vaccines  global  europe  asia  north america  south america  africa  oceania  middle east  caribbean  central america  research assistance us  intl  join alert me now receive biweekly email alerts on new research sign up find out more on our blog pharmaceuticals industry research  market reports sort by title az title za price lowtohigh price hightolow date date older first refine your search close window refine your search title publisher keyword priceusd to date any date last month last  months last  months last year last  years region all regions africa    algeria    angola    benin    botswana    burkina faso    burundi    cameroon    cape verde    central african republic    chad    comoros    the congo    the congo    cote divoire    djibouti    egypt    equatorial guinea    eritrea    ethiopia    gabon    the gambia    ghana    guinea    guineabissau    kenya    lesotho    liberia    libya    madagascar    malawi    mali    mauritania    mauritius    mayotte    morocco    mozambique    namibia    niger    nigeria    reunion    rwanda    sao tome and principe    senegal    seychelles    sierra leone    somalia    south africa    south sudan    sudan    swaziland    tanzania    togo    tunisia    uganda    western sahara    zambia    zimbabwe asia    afghanistan    armenia    azerbaijan    bangladesh    bhutan    brunei    cambodia    china    cocos keeling islands    east timor    georgia    hong kong    india    indonesia    japan    kazakhstan    kyrgyzstan    laos    macau    malaysia    maldives    mongolia    myanmar    nepal    north korea    pakistan    papua new guinea    philippines    russia    singapore    south korea    sri lanka    taiwan    tajikistan    thailand    turkey    turkmenistan    uzbekistan    vietnam caribbean    anguilla    antigua and barbuda    aruba    the bahamas    barbados    british virgin islands    cayman islands    cuba    curacao    dominica    dominican republic    grenada    guadeloupe    haiti    jamaica    martinique    montserrat    netherlands antilles    puerto rico    saint kitts and nevis    saint lucia    saint vincent and the grenadines    sint maarten saint maarten    trinidad and tobago    turks and caicos islands    virgin islands central america    belize    costa rica    el salvador    guatemala    honduras    nicaragua    panama europe    albania    andorra    austria    belarus    belgium    bosnia and herzegovina    bulgaria    croatia    czech republic    denmark    estonia    faroe islands    finland    france    germany    gibraltar    greece    guernsey    hungary    iceland    ireland    isle of man    italy    jersey    kosovo    latvia    liechtenstein    lithuania    luxembourg    macedonia    malta    moldova    monaco    netherlands    norway    poland    portugal    romania    san marino    scotland    serbia and montenegro    slovakia    slovenia    spain    sweden    switzerland    ukraine    united kingdom global middle east    bahrain    cyprus    gaza strip    iran    iraq    israel    jordan    kuwait    lebanon    oman    palestinian territories    qatar    saudi arabia    syria    united arab emirates    yemen north america    bermuda    canada    greenland    mexico    united states oceania    american samoa    australia    cook islands    fiji    french polynesia    guam    kiribati    marshall islands    micronesia federated states of    nauru    new caledonia    new zealand    niue    norfolk island    northern mariana islands    palau    samoa    solomon islands    tonga    tuvalu    vanuatu south america    argentina    bolivia    brazil    chile    colombia    ecuador    falkland islands    french guiana    guyana    paraguay    peru    suriname    uruguay    venezuela search global cancer diagnostics market overview  test volume and sales forecasts by country laboratory universe jul    usd  etiology of major types of cancer estimates of the number of laboratories performing cancer tests as well as tenyear test volume and sales forecasts by country contains  pages and  tables please note the  read more europe hepatitis markers testing market  supplier shares and sales segment forecasts for  immunodiagnostic and nat procedures  hospitals blood banks public health labs commercial labs physician offices jul    usd  analysis of the hepatitis diagnostics market in europe france germany italy spain uk current scientific views on the hepatitis definition epidemiology and etiology are reviewed the report provides the fiveyear test volume and sales forecasts  read more tumor markers testing instrumentation review cancer diagnostic analyzers and strategic profiles of leading suppliers jul    usd  testing the report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products including their sales product portfolios distribution tactics technological knowhow new products in rampd collaborative arrangements and business strategies contains  read more cancer diagnostic instrumentation review tumor marker testing analyzers and strategic profiles of leading suppliers jul    usd  testing the report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products including their sales product portfolios distribution tactics technological knowhow new products in rampd collaborative arrangements and business strategies  read more global hepatitis markers testing market  supplier shares and sales segment forecasts for  immunodiagnostic and nat procedures  hospitals blood banks public health labs commercial labs physician offices jul    usd  analysis of the hepatitis diagnostics market in the us europe france germany italy spain uk and japan current scientific views on the hepatitis definition epidemiology and etiology are reviewed the report provides the year test  read more global chronic idiopathic constipation drug market forecast  jul    usd  propelling the market growth are the modern dietary habits rising elderly population and the improved and efficient drugs in the pipeline linaclotide is the major type of drug popular in this market markt insight the  read more georgia pharmaceuticals and healthcare report q  jul    usd  entice drugmakers to invest in manufacturing facilities the country because of the attractivebusiness environment domestic challenges including the lack of pricing regulation will pose uniquechallenges for drugmakers exporting into the market headline expenditure projections pharmaceuticals  read more global biopreservation market  jul    usd  extended period earlier in the field of tissue engineering cell and tissue transplantation and genetic engineering and preserving of engineered cells and tissues with functional viability in an external environment is a major challenge technavio’s  read more europe chronic idiopathic constipation drug market forecast  jul    usd  is estimated to increase from  million in  and reach  million by  market insights the market has plenty of growth opportunities owing to the unmet needs of cic drugs in certain countries  read more asiapacific chronic idiopathic constipation drug market forecast  jul    usd  by the market is expected to rise from  million in  and reach   million by  market insights the asian cic drug market can be segmented by the type of drug and  read more north america chronic idiopathic constipation drug market forecast  jul    usd  rise from  million in  to  million by  the changing modern dietary habits chances of cancer or other systematic disease leading to cic and the growing increasing elderly population are some of  read more elephantiasis lymphatic filariasis  pipeline review h  jul    usd  filariasis infectious disease pipeline landscape elephantiasis commonly known as lymphatic filariasis occurs when filarial parasites are transmitted to humans through mosquitoes infection is usually acquired in childhood causing hidden damage to the lymphatic system lymphatic  read more erectile dysfunction  pipeline review h  jul    usd  pipeline landscape erectile dysfunction or ed is the inability of a man to have an erection hard enough to have sexual intercourse it can also be known as impotence the predisposing factors include tobacco usage  read more rho associated protein kinase  renal carcinoma antigen ny ren  or rho associated coiled coil containing protein kinase  or p rock  or rock or ec   pipeline review h  jul    usd  summary rho associated protein kinase  renal carcinoma antigen ny ren  or rho associated coiled coil containing protein kinase  or p rock  or rock or ec   rhoassociated protein kinase   read more cholera  pipeline review h  jul    usd  is an acute infectious disease caused by a bacterium vibrio cholera which results in a painless watery diarrhea in humans symptoms of cholera can begin as soon as a few hours or as long as  read more phenylketonuria pku  pipeline review h  jul    usd  pipeline landscape phenylketonuria also called pku is a rare inherited disorder that causes an amino acid called phenylalanine to build up in body symptoms include intellectual disability psychiatric disorders hyperactivity skin rashes poor bone strength  read more insulin resistance  pipeline review h  jul    usd  pipeline landscape insulin resistance ir is a condition in which the bodys cells become resistant to the effects of insulin this occurs when insulin levels are sufficiently high over a prolonged period of time causing  read more bacterial vaginosis  pipeline review h  jul    usd  pipeline landscape bacterial vaginosis bv also known as vaginal bacteriosis is a type of vaginal inflammation caused by overgrowth of bacteria present in vagina symptoms include vaginal itching burning during urination and vaginal discharge may  read more botulism  pipeline review h  jul    usd  is a rare but serious illness the cause is a toxin poison made by a bacterium called clostridium botulinum it occurs naturally in soil food borne botulism comes from eating foods contaminated with the toxin  read more survival motor neuron protein component of gems  or gemin  or smn or smn  pipeline review h  jul    usd  h  survival motor neuron protein component of gems  or gemin  or smn or smn pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies and  read more diabetic macular edema  pipeline review h  jul    usd  edema metabolic disorders pipeline landscape diabetic macular edema dme occurs when blood vessels in the retina of patients with diabetes begin to leak into the macula the part of the eye responsible for detailed central  read more protein glutamine gamma glutamyltransferase  tissue transglutaminase or transglutaminase c or transglutaminase h or transglutaminase  or tgase c or tgase h or tgm or ec   pipeline review h  jul    usd  to the recently published report protein glutamine gamma glutamyltransferase   pipeline review h  protein glutamine gamma glutamyltransferase  tissue transglutaminase or transglutaminase c or transglutaminase h or transglutaminase  or tgase c or  read more respiratory syncytial virus attachment glycoprotein rsv g or g  pipeline review h  jul    usd  approximately  molecules are developed by companies and remaining by the universitiesinstitutes the latest report respiratory syncytial virus attachment glycoprotein rsv g or g  pipeline review h  outlays comprehensive information on the respiratory  read more  nucleotidase ecto  nucleotidase or cd or nte or ec   pipeline review h  jul    usd  ec   pipeline review h   nucleotidase ecto  nucleotidase or cd or nte or ec  pipeline target constitutes close to  molecules out of which approximately  molecules are developed by  read more community acquired pneumonia  pipeline review h  jul    usd  pneumonia infectious disease pipeline landscape communityacquired pneumonia cap is defined as pneumonia acquired outside a hospital or longterm care facility symptoms include cough fever shaking chills confusion headache and loss of appetite risk factors include  read more  prev           next  start new browse consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media company reports reports by country view all market areas view all publishers macrogenics inc  product pipeline review      about us blog contact us faq  usd eur gbp usd ▼ usd eur gbp € eur  usd £ gbp rest of world us toll free  advanced price from €eurusd£gbp view pricing you are here home  categories  company reports select a format  €eurusd£gbp single user electronic pdf  this is a single user license allowing one specific user access to the product the report will be emailed to you the report is sent in pdf format  €eurusd£gbp site license electronic pdf  this is a site license allowing all users within a given geographical location of your organisation access to the product the report will be emailed to you the report is sent in pdf format  €eurusd£gbp enterprisewide electronic pdf  this is an enterprise license allowing all employees within your organisation access to the product the report will be emailed to you the report is sent in pdf format  add to basket order by fax need a quote  our clients have a question email us view faqs recently viewed products partner of research and marketsvaccinating  children in  why choose research and markets worlds largest selection trusted by the best customer focused safe  secure thanks so much you get  stars for the fastest turn around nancy strisik sr administrative assistant to sr director mark fraga global strategic marketing sanofi macrogenics inc  product pipeline review   id  company profile july   pages global markets direct description table of contents samples formats  of  login to access executive summary printer friendly printable pdf brochure send to a friend macrogenics inc  product pipeline review  summary‘macrogenics inc  product pipeline review  ’ provides an overview of the macrogenics inc’s pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by macrogenics inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projectsthe report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basisthe report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantagenote certain sections in the report may be removed or altered based on the availability and relevance of datascope the report provides a snapshot of the pipeline therapeutic landscape of macrogenics inc the report provides overview of macrogenics inc including its business description key facts and locations and subsidiaries the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages the report assesses macrogenics inc’s pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type the report features macrogenics inc’s outlicensed and partnered product portfolio and summarizes its dormant and discontinued projectsreasons to buy evaluate macrogenics inc’s strategic position with total access to detailed information on its product pipeline gain strategically significant competitor information analysis and insights to formulate effective rd strategies identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage identify and understand important and diverse types of therapeutics under development for macrogenics inc identify potential new clients or partners in the target demographic plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics devise corrective measures for pipeline projects by understanding macrogenics inc’s pipeline depth and focus of pipeline therapeutics develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope show less read more note product cover images may vary from those shown  of  login to access executive summary printer friendly printable pdf brochure send to a friend list of tables list of figures macrogenics inc snapshot macrogenics inc overview key information key facts macrogenics inc  research and development overview key therapeutic areas macrogenics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  partnered products partnered productscombination treatment modalities pipeline products  outlicensed products outlicensed productscombination treatment modalities macrogenics inc  pipeline products glance macrogenics inc  late stage pipeline products phase iii productscombination treatment modalities macrogenics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities macrogenics inc  early stage pipeline products preclinical productscombination treatment modalities macrogenics inc  drug profiles margetuximab product description mechanism of action rd progress teplizumab product description mechanism of action rd progress enoblituzumab product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress mga product description mechanism of action rd progress mgd product description mechanism of action rd progress mgd product description mechanism of action rd progress monoclonal antibodies to target dr for oncology product description mechanism of action rd progress monoclonal antibodies to target epha and cd for breast cancer product description mechanism of action rd progress monoclonal antibodies to target ilralpha and cd for melanoma glioblastoma multiforme and medulloblastoma product description mechanism of action rd progress monoclonal antibodies to target ror and cd for oncology product description mechanism of action rd progress monoclonal antibody conjugate to target bh for oncology product description mechanism of action rd progress macrogenics inc  pipeline analysis macrogenics inc  pipeline products by target macrogenics inc  pipeline products by route of administration macrogenics inc  pipeline products by molecule type macrogenics inc  pipeline products by mechanism of action macrogenics inc  recent pipeline updates macrogenics inc  dormant projects macrogenics inc  company statement macrogenics inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesmacrogenics inc key information macrogenics inc key facts macrogenics inc  pipeline by indication  macrogenics inc  pipeline by stage of development  macrogenics inc  monotherapy products in pipeline  macrogenics inc  partnered products in pipeline  macrogenics inc  partnered products combination treatment modalities  macrogenics inc  outlicensed products in pipeline  macrogenics inc  outlicensed products combination treatment modalities  macrogenics inc  phase iii  macrogenics inc  phase ii  macrogenics inc  phase i  macrogenics inc  preclinical  macrogenics inc  pipeline by target  macrogenics inc  pipeline by route of administration  macrogenics inc  pipeline by molecule type  macrogenics inc  pipeline products by mechanism of action  macrogenics inc  recent pipeline updates  macrogenics inc  dormant developmental projects macrogenics inc other locations macrogenics inc subsidiaries list of figuresmacrogenics inc  pipeline by top  indication  macrogenics inc  pipeline by stage of development  macrogenics inc  monotherapy products in pipeline  macrogenics inc  partnered products in pipeline  macrogenics inc  outlicensed products in pipeline  macrogenics inc  pipeline by top  target  macrogenics inc  pipeline by route of administration  macrogenics inc  pipeline by molecule type  macrogenics inc  pipeline products by top  mechanism of action  note product cover images may vary from those shown  of  loading  of  note product cover images may vary from those shown related products macrogenics inc  product pipeline review    company profile may  from €eurusd£gbp macrogenics inc mgnx  financial and strategic swot analysis review  swot analysis july  from €eurusd£gbp thrombogenics nv  product pipeline review    company profile june  from €eurusd£gbp psychogenics inc  product pipeline review    company profile june  from €eurusd£gbp somagenics inc  product pipeline review    company profile july  from €eurusd£gbp macrogenics inc company profile  outlook business segments competitors goods and services swot and financial analysis  company profile november  from €eurusd£gbp macrogenics inc  mergers  acquisitions ma partnerships  alliances and investment report  mergers and acquisitions profiles may  from €eurusd£gbp thrombogenics nv thr  financial and strategic swot analysis review  swot analysis may  from €eurusd£gbp macrogenics inc  company profile july  €eurusd£gbp sorrento therapeutics inc  product pipeline review    company profile june  from €eurusd£gbp close macrogenics inc  product pipeline review   close ask a question required information product macrogenics inc  product pipeline review   your question your contact details title mr mrs dr miss ms prof first name last name email address country please select  united states united kingdom germany canada australia  afghanistan albania algeria american samoa andorra angola anguilla antarcticacasey antarcticascott antigua and barbuda argentina armenia aruba ascension island ashmore and cartier islands atlantic east atlantic west australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana brazil british virgin islands brunei bulgaria burkina faso burma burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island clipperton island cocos keeling islands colombia comoros congo cook islands costa rica croatia cuba curaco cyprus czech republic democratic republic of congo denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands islas malvinas faroe islands fiji islands finland france french guiana french polynesia gabon gambia gaza strip georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy ivory coast ivory coast cote divoire jamaica japan jordan kazakhstan kenya kiribati kosovo kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte islands mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria niue norfolk islands north korea northern ireland northern marianas norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar reunion romania russia rwanda saint christopher nevis saint helena saint kitts and nevis saint lucia saint martin saint vincent and the grenadines samoa san marino sao tome saudi arabia scotland senegal serbia serbia and montenegro seychelles sierra leone singapore sint maarten slovakia slovenia solomon islands somalia south africa south korea spain sri lanka sudan suriname swaziland sweden switzerland syria tahiti taiwan tajikistan tanzania thailand togo trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city holy see venezuela vietnam virgin islands wallis and futuna west bank west indies western sahara yemen yugoslavia zaire zambia zimbabwe phone number                                                                                                                                                                                                                                    we request your telephone number so we can contact you in the event we have difficulty reaching you via email we aim to respond to all questions on the same business day close send to a friend  required information friends details full name email address message to friend your contact details full name email address close request a quote please complete the below form and click send request to obtain a pdf quotation and order form this document will be available for immediate download and will also be emailed to you  required information your address address  address  address  city postalzip code country please select  united states united kingdom germany canada australia  afghanistan albania algeria american samoa andorra angola anguilla antarcticacasey antarcticascott antigua and barbuda argentina armenia aruba ascension island ashmore and cartier islands atlantic east atlantic west australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana brazil british virgin islands brunei bulgaria burkina faso burma burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island clipperton island cocos keeling islands colombia comoros congo cook islands costa rica croatia cuba curaco cyprus czech republic democratic republic of congo denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands islas malvinas faroe islands fiji islands finland france french guiana french polynesia gabon gambia gaza strip georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy ivory coast ivory coast cote divoire jamaica japan jordan kazakhstan kenya kiribati kosovo kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte islands mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria niue norfolk islands north korea northern ireland northern marianas norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar reunion romania russia rwanda saint christopher nevis saint helena saint kitts and nevis saint lucia saint martin saint vincent and the grenadines samoa san marino sao tome saudi arabia scotland senegal serbia serbia and montenegro seychelles sierra leone singapore sint maarten slovakia slovenia solomon islands somalia south africa south korea spain sri lanka sudan suriname swaziland sweden switzerland syria tahiti taiwan tajikistan tanzania thailand togo trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city holy see venezuela vietnam virgin islands wallis and futuna west bank west indies western sahara yemen yugoslavia zaire zambia zimbabwe state your details title mr mrs dr miss ms prof first name last name organisation email address phone number                                                                                                                                                                                                                                    po number if applicable product format license format properties price single user electronic pdf the report will be emailed to you the report is sent in pdf format this is a single user license allowing one specific user access to the product €eurusd£gbp site license electronic pdf the report will be emailed to you the report is sent in pdf format this is a site license allowing all users within a given geographical location of your organisation access to the product €eurusd£gbp enterprisewide electronic pdf the report will be emailed to you the report is sent in pdf format this is an enterprise license allowing all employees within your organisation access to the product €eurusd£gbp  the price quoted above is only valid for  days please submit your order within that time frame to avail of this price as all prices are subject to change bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one